Head-to-head · WeighScore
Remi Meds vs VitaFusions IV
The verdict
VitaFusions IV takes it — 62.3/100 to 48.4/100.
VitaFusions IV grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. VitaFusions IV (vitafusionsiv.com) offers semaglutide and medical weight loss services in Dallas, TX.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Remi Meds | VitaFusions IV |
|---|---|---|
| WeighScore | 48.4/100 | 62.3/100 |
| Grade | C | C |
| Scorecard rank | #493 | #274 |
| Semaglutide | $249/mo (0.25 mg dose, compounded) | $149/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide | $349/mo (2.25 mg dose, compounded) | $189/mo (all doses, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #493 · C
Strengths
- Names its compounding pharmacy (Strive Pharmacy, Gilbert AZ) — stronger transparency than peers
- LegitScript verification badge on the homepage
- Publishes 503A FDCA compliance language on the tirzepatide page
- Per-dose-tier pricing fully shown — no 'as low as' floor-only obfuscation
- Operating corporate entity disclosed (T-C Health Co)
Where it loses points
- No named medical director, founder, or physician on any public page
- States served not listed — 'nationwide' claim with no per-state detail
- Clinical care runs through Beluga Health, a network a 2026 StatNews analysis tied to many FDA-warned GLP-1 companies (Remi Meds itself not FDA-warned)
- Year founded and corporate history are opaque
- Two phone numbers and a secondary 'Rekindle RX' email hint at shared infrastructure
Graded #274 · C
Strengths
- Semaglutide confirmed from page metadata
- Published flat package pricing: semaglutide from $149, tirzepatide $189 for a 7-week supply, no insurance/memberships/contracts
Where it loses points
- Advertised prices are 7-week package prices, not monthly; homepage banner ('$199 for 7 weeks') conflicts with the program page ('Starting $149')
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.